The introduction of nicotinamide to be a nicotine substitution in e-cigarette and smokeless items represents a major regulatory obstacle for the FDA. Nicotinamide doesn't have nicotinic receptor agonist action and is understood to work as a sedative at large dosages6. The claims made by Nicotine River, ECBlend, and various vendors that their produc